CSD201204 An Actual Use Study of P12 Electronic Nicotine Delivery System Among U.S. Adult Smokers
NCT05960305 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1845
Last updated 2024-02-23
Summary
The purpose of this Actual Use Study (AUS) is to investigate how United States (US) adult tobacco consumers 21 to 60 years of age, inclusive, who are regular smokers (≥5 cigarettes/day on at least 20 of the past 30 days) will use the Cartridge-based ENDS investigational products (Study IP) over a 6-week Actual Use Period (AUP) in their real-life/naturalistic environments. Subjects will be able to choose freely among the Study IP available in one of the three study arms to which they are randomly assigned. The three study arms are organized by Study IP flavor categories: tobacco, menthol, and non-tobacco-non-menthol (NTNM). Subjects will self-report their ad libitum use of the Study IP as well as use of Combustible Cigarettes (CC) and any other tobacco- and nicotine-containing product (TNP) on a daily basis using an electronic diary (eDiary).
Conditions
- Smoking, Tobacco
Interventions
- OTHER
-
P1213416
Tobacco Flavor
- OTHER
-
P1213422
Tobacco Flavor
- OTHER
-
P1213716
Tobacco Flavor
- OTHER
-
P1213722
Tobacco Flavor
- OTHER
-
P1211216
Menthol Flavor
- OTHER
-
P1211222
Menthol Flavor
- OTHER
-
P1213616
Menthol Flavor
- OTHER
-
P1213622
Menthol Flavor
- OTHER
-
P1213816
NTNM Flavor
- OTHER
-
P1213822
NTNM Flavor
- OTHER
-
P1211916
NTNM Flavor
- OTHER
-
P1211922
NTNM Flavor
Sponsors & Collaborators
-
RAI Services Company
lead INDUSTRY
Principal Investigators
-
Kristen Jordan, PhD · RAIS
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-09-15
- Primary Completion
- 2024-01-22
- Completion
- 2024-01-28
Countries
- United States
Study Locations
More Related Trials
-
Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods.
NCT03700112 ·Status: COMPLETED ·Phase: NA
-
Use Behavior, Nicotine Uptake, and Subjective Effects Comparison of Tobacco and Menthol e-Liquids by ENDS Consumers
NCT05134415 ·Status: COMPLETED ·Phase: NA
-
CSD170304: Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes
NCT03294356 ·Status: COMPLETED ·Phase: NA
-
Assessing the Effect of Flavor on ENDS Users' Experiences and Exposures
NCT04192032 ·Status: COMPLETED ·Phase: NA
-
Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
NCT03580525 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Abuse Liability for Eight Electronic Nicotine Products
NCT07323511 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
CSD231005 Nicotine Pouch Biomarkers of Exposure
NCT06303115 ·Status: COMPLETED ·Phase: NA
-
Abuse Liability for Five Modern Oral Nicotine Products
NCT07132814 ·Status: RECRUITING ·Phase: NA
-
Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study
NCT04231539 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery Systems
NCT07323563 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Different E-cigarette Cooling Flavors on Adults' Sensory Experience TCORS 3.0
NCT05932693 ·Status: COMPLETED ·Phase: NA
-
CSD201001: Study to Assess Elements of Abuse Liability for Three Nicotine Pouches
NCT05129657 ·Status: COMPLETED ·Phase: NA
-
CSD210202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery Systems
NCT04751461 ·Status: COMPLETED ·Phase: NA
-
Assess the Influence of Nicotine Flux and Nicotine Form on Subjective Effects Related to Dependency
NCT05430334 ·Status: COMPLETED ·Phase: NA
-
CSD190301: A Study to Assess Elements of Abuse Liability for Two Dissolvable Nicotine Lozenge Tobacco Products
NCT04167384 ·Status: COMPLETED ·Phase: NA
-
Comparing Nicotine Delivery, Subjective Effects, and Sensory Experiences of Tobacco Users Using Oral Nicotine Products and Electronic Cigarettes [ZYN Study]
NCT05030194 ·Status: COMPLETED ·Phase: NA
-
CSD170301: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Four Different Electronic Cigarettes
NCT03105804 ·Status: COMPLETED ·Phase: NA
-
Randomized Controlled Trial to Evaluate the Impact of ZYN Nicotine Pouch Products on Cigarette Usage and BoExp in Adult Smokers Over a 12-week Period
NCT06568900 ·Status: COMPLETED ·Phase: NA
-
Characterize the Nicotine Uptake and Subjective Effects With Use of JUUL Electronic Nicotine Delivery Systems
NCT04123041 ·Status: COMPLETED ·Phase: NA
-
A Study to Characterize Puff Topography With Use of JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers
NCT03596034 ·Status: COMPLETED ·Phase: NA
-
Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers
NCT03593239 ·Status: COMPLETED ·Phase: NA
-
United States Pre-Market Tobacco Application Pharmacokinetics
NCT03719391 ·Status: COMPLETED ·Phase: NA
-
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
NCT02870218 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users
NCT03710590 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants
NCT03379740 ·Status: COMPLETED ·Phase: NA